Karnataka govt scouts for collaboration with Switzerland for AI, ML, blockchain & related technologies for pharma & healthcare
The Karnataka
government is scouting for collaboration with Switzerland in the area of
artificial intelligence, machine learning, blockchain, big data and other
related technologies which are much sought after in the pharmaceutical and
healthcare sector.
The state which is the information technology capital of the world is seen to
be ideally positioned to maximise the expertise from Switzerland which is the
hub for innovations in healthcare, according to the government.
An Indo-Swiss healthcare initiative highlighted the impact of technologies and
creating a path towards digital healthcare. During the Digital Health Week in
2019, India and Switzerland are taking a closer collaboration and are
positioned adequately to take many of its efforts through a week long market
exploration programme curated by Swissnex, a Switzerland-government-promoted
organisation.
In Bengaluru, the digital health conclave was a platform to build networks in
the areas of AI, machine learning, augmented reality, robotics, big data
analytics to enable collaborators to have exchange programmes like
university-industry, university to university, industry and government.
According to Ahmed Abdulla, founder and CEO, Digipharm, the company has
developed the first tech platform for value-based pricing. This model
encourages risk sharing between patient, hospital and insurance providers.
Since over 70 per cent of the payments are out of pocket, a blockchain solution
would encourage paying for performance than volume.
In a dedicated session on AI, ML for global health, Dr. Prajwal, founder &
CSO, Clemedi highlighted the path to better medical diagnosis using machine
learning. “Technology applications could enable faster diagnosis. Detection of
TB through machine learning will help decipher the genetic code that guides
doctors for personalised therapy. It will also give medical practitioners a
direction on whether the drug will work or not.”
In this regard the patented solution from Clemedi has built in algorithms based
on cloud based platform. Just as India gears up to eradicate TB and offset the
challenge of drug resistant TB, such tests would enable speedy and accurate
detection for quicker access of therapy, he said.
Considerable promising medical and point of care devices under validation
across the country are yet to enter the market. Now validation requires data
which needs to be presented to the regulatory authorities for approval of
market entry, said Deepanwita Chattopadhyay - chairman & CEO, IKP Knowledge
Park who chaired the session on AI, ML for Global Health.
Dr. Shravan Subramanyam, managing director, Roche Diagnostics India and Prof.
Paul C Salins, sr. vice president, NH Narayana Health and medical director,
Mazumdar Shaw Medical Center said that digital health is critical to leapfrog
in patient care.
While there are challenges like marketability of digital health technology for
start-ups, there is a need to access multi- entrepreneurial capability which
create a cluster of capabilities. Only such an ecosystem could help healthcare
outcomes be optimised and also provide an opportunity for further development
of the technology, said Prof. Salins.
Dr Subramanyam noted that there was a need to widen our reach to deliver
digital healthcare. Personalised health required data for targeted care and
therefore there was need to invest in data coming in from specific start-ups
which had the expertise in it.
Comments
Post a Comment